The IPO Illusion: Separating Buzz from Substance in the Market’s Next Generation

The recent public offerings of SpaceX and the anticipation surrounding Anthropic and OpenAI have created a frenzy among investors, who are eager to get in on what they perceive as the next trillion-dollar company. However, this excitement is not necessarily justified. We should examine whether we’re witnessing a repeat of history, where hype and speculation overshadowed real value creation.

The notion that missing an initial public offering (IPO) is like buying a lottery ticket when the jackpot hits $1 billion is an apt analogy. While investors who bought Nvidia in its IPO a decade ago are now worth approximately $1.8 million today, it’s essential to look beyond this phenomenon and examine the underlying financials of these companies.

One reason for the excitement surrounding these companies lies in their impressive growth rates and projected valuations. Anthropic’s annualized run rate has crossed $47 billion, with publicly guided projections reaching over $50 billion by May. OpenAI’s numbers are equally impressive, with a $25 billion annualized run rate as of early 2026.

However, these figures don’t necessarily translate to long-term success. As Matt Witheiler of Wellington Management points out, the dotcom bust served as a stark reminder that investors often buy companies based on their story rather than their underlying financials. “You show me the numbers,” he says, “and it’s obviously real or not.”

In evaluating these companies, following the revenue becomes crucial. While impressive growth rates are certainly desirable, they must be accompanied by a sustainable business model and an addressable market that is unbounded. This is where SpaceX’s orbital data centers come into play, offering a glimpse into the company’s potential for long-term success.

Investors would do well to read the prospectus – not just the headlines. The S-1 document filed by SpaceX with the Securities and Exchange Commission provides a detailed overview of the company’s financials, governance structure, and growth prospects. It also reveals that control of SpaceX resides firmly with Elon Musk via billions of Class B super-voting shares.

The prospectus is often overlooked by retail investors, who are more likely to be swayed by sensational headlines and grandiose promises. However, this approach can lead to costly mistakes, as seen in the case of Abgenix and Enzo Biochem, which had stellar debuts but eventually cooled down while patient investors backing Moderna saw significant returns.

The hype surrounding Anthropic and OpenAI’s IPOs is understandable, given their impressive growth rates and projected valuations. However, it’s essential for investors to separate buzz from substance by evaluating these companies based on their underlying financials, revenue growth, and addressable market potential. By doing so, they can avoid falling prey to the IPO illusion – a phenomenon that has led many investors astray in the past.

Ultimately, the success of these companies will depend not just on their ability to execute on their growth plans but also on their capacity to adapt to changing market conditions. As the market continues to evolve, one thing is certain: only time will tell which companies will truly live up to their promise and become the next trillion-dollar giants.